These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
203 related items for PubMed ID: 21735444
1. PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma. Yamamoto S, Tsuda H, Takano M, Iwaya K, Tamai S, Matsubara O. J Pathol; 2011 Oct; 225(2):189-94. PubMed ID: 21735444 [Abstract] [Full Text] [Related]
2. Multifocal endometriotic lesions associated with cancer are clonal and carry a high mutation burden. Anglesio MS, Bashashati A, Wang YK, Senz J, Ha G, Yang W, Aniba MR, Prentice LM, Farahani H, Li Chang H, Karnezis AN, Marra MA, Yong PJ, Hirst M, Gilks B, Shah SP, Huntsman DG. J Pathol; 2015 Jun; 236(2):201-9. PubMed ID: 25692284 [Abstract] [Full Text] [Related]
3. Distinct β-catenin and PIK3CA mutation profiles in endometriosis-associated ovarian endometrioid and clear cell carcinomas. Matsumoto T, Yamazaki M, Takahashi H, Kajita S, Suzuki E, Tsuruta T, Saegusa M. Am J Clin Pathol; 2015 Sep; 144(3):452-63. PubMed ID: 26276776 [Abstract] [Full Text] [Related]
4. Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations. Yamamoto S, Tsuda H, Takano M, Tamai S, Matsubara O. Mod Pathol; 2012 Apr; 25(4):615-24. PubMed ID: 22157930 [Abstract] [Full Text] [Related]
5. The role of p53 mutation in the carcinomas arising from endometriosis. Akahane T, Sekizawa A, Purwosunu Y, Nagatsuka M, Okai T. Int J Gynecol Pathol; 2007 Jul; 26(3):345-51. PubMed ID: 17581423 [Abstract] [Full Text] [Related]
6. PIK3CA mutations in advanced ovarian carcinomas. Wang Y, Helland A, Holm R, Kristensen GB, Børresen-Dale AL. Hum Mutat; 2005 Mar; 25(3):322. PubMed ID: 15712344 [Abstract] [Full Text] [Related]
7. ACTN4 gene amplification and actinin-4 protein overexpression drive tumour development and histological progression in a high-grade subset of ovarian clear-cell adenocarcinomas. Yamamoto S, Tsuda H, Honda K, Takano M, Tamai S, Imoto I, Inazawa J, Yamada T, Matsubara O. Histopathology; 2012 Jun; 60(7):1073-83. PubMed ID: 22348389 [Abstract] [Full Text] [Related]
8. Cumulative alterations of p27-related cell-cycle regulators in the development of endometriosis-associated ovarian clear cell adenocarcinoma. Yamamoto S, Tsuda H, Miyai K, Takano M, Tamai S, Matsubara O. Histopathology; 2010 May; 56(6):740-9. PubMed ID: 20546339 [Abstract] [Full Text] [Related]
9. Targeted next-generation sequencing for molecular diagnosis of endometriosis-associated ovarian cancer. Er TK, Su YF, Wu CC, Chen CC, Wang J, Hsieh TH, Herreros-Villanueva M, Chen WT, Chen YT, Liu TC, Chen HS, Tsai EM. J Mol Med (Berl); 2016 Jul; 94(7):835-47. PubMed ID: 26920370 [Abstract] [Full Text] [Related]
10. Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma. Rahman M, Nakayama K, Rahman MT, Nakayama N, Ishikawa M, Katagiri A, Iida K, Nakayama S, Otsuki Y, Shih IeM, Miyazaki K. Hum Pathol; 2012 Dec; 43(12):2197-206. PubMed ID: 22705003 [Abstract] [Full Text] [Related]
11. PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma. Yamamoto S, Tsuda H, Takano M, Tamai S, Matsubara O. Virchows Arch; 2012 Jan; 460(1):77-87. PubMed ID: 22120431 [Abstract] [Full Text] [Related]
12. PIK3CA gene mutations and amplifications in Chinese patients with ovarian clear cell carcinoma. Jiang G, Huang Z, Zhang S, Wang L. Cancer Invest; 2013 Dec; 31(10):639-44. PubMed ID: 24299208 [Abstract] [Full Text] [Related]
13. Mutation of the PIK3CA gene in ovarian and breast cancer. Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS, Cristiano BE, Pearson RB, Phillips WA. Cancer Res; 2004 Nov 01; 64(21):7678-81. PubMed ID: 15520168 [Abstract] [Full Text] [Related]
14. Aberrant expression of the mammalian target of rapamycin, hypoxia-inducible factor-1α, and glucose transporter 1 in the development of ovarian clear-cell adenocarcinoma. Kato M, Yamamoto S, Takano M, Matsubara O, Furuya K. Int J Gynecol Pathol; 2012 May 01; 31(3):254-63. PubMed ID: 22498943 [Abstract] [Full Text] [Related]
15. Patterns of loss of heterozygosity at 10q23.3 and microsatellite instability in endometriosis, atypical endometriosis, and ovarian carcinoma arising in association with endometriosis. Ali-Fehmi R, Khalifeh I, Bandyopadhyay S, Lawrence WD, Silva E, Liao D, Sarkar FH, Munkarah AR. Int J Gynecol Pathol; 2006 Jul 01; 25(3):223-9. PubMed ID: 16810057 [Abstract] [Full Text] [Related]
16. Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage. Jiang X, Morland SJ, Hitchcock A, Thomas EJ, Campbell IG. Cancer Res; 1998 Apr 15; 58(8):1707-12. PubMed ID: 9563487 [Abstract] [Full Text] [Related]
17. Malignant transformation of endometriosis: application of laser microdissection for analysis of genetic alterations according to pathological changes. Sekizawa A, Amemiya S, Otsuka J, Saito H, Farina A, Okai T, Tachikawa T. Med Electron Microsc; 2004 Jun 15; 37(2):97-100. PubMed ID: 15221651 [Abstract] [Full Text] [Related]
18. K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma. Otsuka J, Okuda T, Sekizawa A, Amemiya S, Saito H, Okai T, Kushima M, Tachikawa T. Med Electron Microsc; 2004 Sep 15; 37(3):188-92. PubMed ID: 15449112 [Abstract] [Full Text] [Related]
19. Ovarian clear cell carcinoma--bad endometriosis or bad endometrium? Gounaris I, Charnock-Jones DS, Brenton JD. J Pathol; 2011 Oct 15; 225(2):157-60. PubMed ID: 21898874 [Abstract] [Full Text] [Related]
20. The association between endometriosis and ovarian cancer: a review of histological, genetic and molecular alterations. Munksgaard PS, Blaakaer J. Gynecol Oncol; 2012 Jan 15; 124(1):164-9. PubMed ID: 22032835 [Abstract] [Full Text] [Related] Page: [Next] [New Search]